GSK (NYSE: GSK)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-27 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.760 | 0.880 | 0.1200 | ||||
REV | 11.700B | 13.126B | 1.426B |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of GSK (NYSE: GSK) through any online brokerage.
Other companies in GSK’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Roivant Sciences (NASDAQ:ROIV).
The latest price target for GSK (NYSE: GSK) was reported by DZ Bank on Friday, February 11, 2022. The analyst firm set a price target for 0.00 expecting GSK to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
The stock price for GSK (NYSE: GSK) is $43.77 last updated June 29, 2022, 7:59 PM UTC.
A quarterly cash dividend of $0.34 per share of Class A Common Stock. The quarterly cash dividend was payable on July 1, 2022 to stockholders of record on May 19, 2022.
GSK’s Q2 earnings are confirmed for Wednesday, July 27, 2022.
There is no upcoming split for GSK.
GSK is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.